Literature DB >> 34799693

Novel disease associations with schizophrenia genetic risk revealed in ~400,000 UK Biobank participants.

Ruyue Zhang1, Arvid Sjölander1, Alexander Ploner1, Donghao Lu1,2, Cynthia M Bulik1,3,4, Sarah E Bergen5.   

Abstract

Schizophrenia is a serious mental disorder with considerable somatic and psychiatric morbidity. It is unclear whether comorbid health conditions predominantly arise due to shared genetic risk or consequent to having schizophrenia. To explore the contribution of genetic risk for schizophrenia, we analysed the effect of schizophrenia polygenic risk scores (PRS) on a broad range of health problems in 406 929 individuals with no schizophrenia diagnosis from the UK Biobank. Diagnoses were derived from linked health data including primary care, hospital inpatient records, and registers with information on cancer and deaths. Schizophrenia PRS were generated and tested for associations with general health conditions, 16 ICD10 main chapters, and 603 diseases using linear and logistic regressions. Higher schizophrenia PRS was significantly associated with poorer overall health ratings, more hospital inpatient diagnoses, and more unique illnesses. It was also significantly positively associated with 4 ICD10 chapters: mental disorders; respiratory diseases; digestive diseases; and pregnancy, childbirth and the puerperium, but negatively associated with musculoskeletal disorders. Thirty-one specific phenotypes were significantly associated with schizophrenia PRS, and the 19 novel findings include several musculoskeletal diseases, respiratory diseases, digestive diseases, varicose veins, pituitary hyperfunction, and other peripheral nerve disorders. These findings extend knowledge of the pleiotropic effect of genetic risk for schizophrenia and offer insight into how some conditions often comorbid with schizophrenia arise. Additional studies incorporating the genetic basis of hormone regulation and involvement of immune mechanisms in the pathophysiology of schizophrenia may further elucidate the biological mechanisms underlying schizophrenia and its comorbid conditions.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Year:  2021        PMID: 34799693      PMCID: PMC9106855          DOI: 10.1038/s41380-021-01387-5

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   13.437


  49 in total

Review 1.  Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden.

Authors:  E Cantor-Graae; L G Nordström; T F McNeil
Journal:  Schizophr Res       Date:  2001-03-01       Impact factor: 4.939

2.  Genetic correlation between smoking behaviors and schizophrenia.

Authors:  Sarah M Hartz; Amy C Horton; Dana B Hancock; Timothy B Baker; Neil E Caporaso; Li-Shiun Chen; John E Hokanson; Sharon M Lutz; Mary L Marazita; Daniel W McNeil; Carlos N Pato; Michele T Pato; Eric O Johnson; Laura J Bierut
Journal:  Schizophr Res       Date:  2017-03-08       Impact factor: 4.939

3.  Medical comorbidity in schizophrenia.

Authors:  Timothy J R Lambert; Dennis Velakoulis; Christos Pantelis
Journal:  Med J Aust       Date:  2003-05-05       Impact factor: 7.738

4.  Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study.

Authors:  Casey Crump; Marilyn A Winkleby; Kristina Sundquist; Jan Sundquist
Journal:  Am J Psychiatry       Date:  2013-03       Impact factor: 18.112

5.  Higher prevalence of dementia in patients with schizophrenia: A nationwide population-based study.

Authors:  Hyemin Ku; Eui-Kyung Lee; Kyoung-Uk Lee; Min-Young Lee; Jin-Won Kwon
Journal:  Asia Pac Psychiatry       Date:  2016-03-30       Impact factor: 2.538

Review 6.  Psychiatric comorbidities and schizophrenia.

Authors:  Peter F Buckley; Brian J Miller; Douglas S Lehrer; David J Castle
Journal:  Schizophr Bull       Date:  2008-11-14       Impact factor: 9.306

Review 7.  Anxiety comorbidity in schizophrenia.

Authors:  Raphael J Braga; Graham P Reynolds; Samuel G Siris
Journal:  Psychiatry Res       Date:  2013-08-07       Impact factor: 3.222

8.  Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study.

Authors:  Paul Lichtenstein; Benjamin H Yip; Camilla Björk; Yudi Pawitan; Tyrone D Cannon; Patrick F Sullivan; Christina M Hultman
Journal:  Lancet       Date:  2009-01-17       Impact factor: 79.321

9.  An atlas of genetic correlations across human diseases and traits.

Authors:  Brendan Bulik-Sullivan; Hilary K Finucane; Verneri Anttila; Alexander Gusev; Felix R Day; Po-Ru Loh; Laramie Duncan; John R B Perry; Nick Patterson; Elise B Robinson; Mark J Daly; Alkes L Price; Benjamin M Neale
Journal:  Nat Genet       Date:  2015-09-28       Impact factor: 38.330

Review 10.  The epidemiologic evidence linking autoimmune diseases and psychosis.

Authors:  Michael E Benros; William W Eaton; Preben B Mortensen
Journal:  Biol Psychiatry       Date:  2013-10-03       Impact factor: 13.382

View more
  1 in total

Review 1.  Dysbindin-1, BDNF, and GABAergic Transmission in Schizophrenia.

Authors:  Rachel Jun; Wen Zhang; Nicholas J Beacher; Yan Zhang; Yun Li; Da-Ting Lin
Journal:  Front Psychiatry       Date:  2022-06-22       Impact factor: 5.435

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.